| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 858.10M | 1.67B | 1.03B | -720.40M | 1.50B | 634.43M |
| Gross Profit | 353.00M | 1.67B | 1.03B | -1.29B | 1.49B | 634.43M |
| EBITDA | 13.80M | 49.70M | 31.40M | -48.40M | 42.19M | 52.04M |
| Net Income | -7.90M | 3.90M | 18.70M | -33.70M | 27.29M | 21.19M |
Balance Sheet | ||||||
| Total Assets | 13.51B | 12.76B | 12.13B | 11.14B | 9.42B | 8.86B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 138.00M | 146.00M | 204.60M | 70.09M | 105.35M |
| Total Debt | 203.80M | 206.20M | 209.30M | 213.23M | 49.46M | 71.44M |
| Total Liabilities | 13.22B | 12.44B | 11.77B | 10.81B | 8.96B | 8.37B |
| Stockholders Equity | 293.30M | 314.40M | 359.90M | 333.12M | 458.17M | 487.07M |
Cash Flow | ||||||
| Free Cash Flow | 44.70M | 37.80M | -35.70M | -80.43M | 20.69M | 49.34M |
| Operating Cash Flow | 45.90M | 38.60M | -34.90M | -76.92M | 24.32M | 50.20M |
| Investing Cash Flow | 4.60M | 5.00M | 29.50M | 52.05M | -3.64M | 1.88M |
| Financing Cash Flow | -33.90M | -49.70M | -49.80M | 121.30M | -52.25M | -61.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £701.93M | -66.96 | -2.53% | 8.03% | -48.03% | -289.17% | |
71 Outperform | £29.36B | 11.63 | 20.51% | 1.56% | 37.94% | 291.37% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £7.42B | -11.68 | -49.24% | 7.48% | -34.62% | -19.20% | |
67 Neutral | £392.55M | -86.39 | -20.10% | ― | 29.58% | 17.32% | |
62 Neutral | £616.15M | -16.18 | -76.14% | ― | -35.05% | 74.73% | |
58 Neutral | £68.35M | 37.88 | 9.65% | 9.33% | -52.34% | -65.35% |
Chesnara plc has confirmed that its issued share capital comprises 230,899,448 ordinary shares of 5 pence each, with no shares held in treasury, giving a total of 230,899,448 voting rights. The disclosure, made in line with UK transparency rules, provides investors with the reference figure needed to assess and report any holdings or changes in their interest in the company, reinforcing regulatory compliance and transparency for shareholders.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £335.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara plc has received UK regulatory approval for its proposed acquisition of HSBC Life (UK) Limited for £260 million, with plans to complete the transaction by the end of January 2026. This acquisition aligns with Chesnara’s strategy of expanding through value-adding acquisitions, potentially enhancing its market position and offering new growth opportunities in the life and pensions sector.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £315.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara plc has announced a change in its registered office location to Winckley Square, Preston, effective December 11, 2025. This change is in compliance with UK Market Abuse Regulation and FCA’s Disclosure and Transparency Rules, indicating a strategic move to enhance operational efficiency and stakeholder transparency.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £315.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC has announced its total voting rights, with its issued share capital comprising 230,803,427 ordinary shares, each carrying one voting right. This announcement is in line with the company’s compliance with the FCA’s Disclosure Guidance and Transparency Rules, providing shareholders the necessary information to assess their interests in the company.
The most recent analyst rating on (GB:CSN) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara plc has announced that its Group CEO, Steve Murray, and Group CFO, Tom Howard, have acquired additional ordinary shares in the company through a dividend reinvestment plan. This acquisition reflects confidence in the company’s ongoing strategy and financial health, as Chesnara continues to focus on efficient policy management and expansion through new business and acquisitions.
The most recent analyst rating on (GB:CSN) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC announced that its issued share capital consists of 230,758,230 ordinary shares, each carrying one voting right, which shareholders can use to determine their interest in the company. This announcement aligns with Chesnara’s commitment to transparency and may impact stakeholders by clarifying their voting rights and interests in the company.
The most recent analyst rating on (GB:CSN) stock is a Hold with a £287.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.